Vocal cord polyps
Conditions
Interventions
experimental group:administering sugammadex sodium injection for neuromuscular block reversal
control group:dministering neostigmine injection for neuromuscular block reversal
Sponsors
Guabgzhou First People‘s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Volunteers voluntarily cooperate with the study and sign the informed consent form; 2.Age 18-65 years; 3.ASA Class I-III; 4.Planned to undergo vocal cord polyp resection under suspension laryngoscopy;
Exclusion criteria
Exclusion criteria: 1.Known or suspected neuromuscular diseases; 2.Pregnant or lactating women; 3.Participants with known or suspected allergies to sugammadex sodium injection, neostigmine methylsulfate injection, or rocuronium, or those with contraindications to these drugs; 4.Use of other investigational drugs or other interventions for treatment within 6 months; 5.Sufficient recovery of neuromuscular blockade to a Train-of-Four Ratio (TOFR) >= 0.9 upon admission to the Post-Anesthesia Care Unit (PACU); 6.Known or suspected neuromuscular diseases;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| extubation time; | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of postoperative recovery;Patient Satisfaction;Perioperative Hemodynamics;PACU Length of Stay; | — |
Countries
China
Contacts
Public ContactZheng Bin
Guabgzhou First People‘s Hospital
Outcome results
None listed